Wednesday, March 05, 2025 | 02:52 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Biological E to invest Rs 300 crore on new vaccines plant

The new plant will come up at a special economic zone

Photo: Shutterstock
Premium

Photo: Shutterstock

B Dasarath Reddy Hyderabad
Hyderabad-based vaccine maker Biological E (BE) today said it would be investing up to Rs 300 crore in a new plant coming up in the special economic zone (SEZ) here. 

This investment is in line with and part of Rs 1,000 crore outlay already earmarked in Hyderabad Genome Valley across BE's vaccines and pharma businesses, according to the company's managing director Mahima Datla.

The construction of the new vaccine manufacturing facility, for which the foundation stone was laid on Monday, on about 29 acres of land would be completed by April 2018 and the commercial production is expected to begin

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in